Hot Features
Premium
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Zeitraum:
Zeichenmodus:
| Volumen | 105.089 |
|
|||||
| News | - | ||||||
| Tageshoch | 1,07 | Niedrig Hoch |
|||||
| Tagestief | 0,93 | ||||||
| Name | Symbol | Markt | Aktientyp |
|---|---|---|---|
| Quince Therapeutics Inc | QNCX | NASDAQ | Common Stock |
| Änderung | Änderung % | Aktuell | Zeit
|
|
|---|---|---|---|---|
| -0,0814 | -8,19% | 0,912 | 02:00:00 |
| Handelsbeginn | Niedrig | Hoch | Schlusskurs | Handelsende |
|---|---|---|---|---|
| 1,03 | 0,93 | 1,07 | 0,96 | 0,9934 |
| Trades | Volumen | VWAP | Finanzielles Volumen | Durchsch. Volumen | 52 Week Range |
|---|---|---|---|---|---|
| 351 | 105.089 | US$ 1,01 | US$ 106.321 | - | 0,84 - 1,74 |
| Letzte Trade | Typ | Menge | Kurs | Währung |
|---|---|---|---|---|
| 00:13:13 | formt | 500 | US$ 0,912 | USD |
Finanzwerte QNCX
| Börsenwert | Emittierte Aktien | Float | Erlöse | Gewinn/Verlust | Ertrag je Aktie | Kurs-Gewinn-Verhältnis |
|---|---|---|---|---|---|---|
| 39,87M | 42,87M | - | 0 | -31,39M | -0,73 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
News Quince Therapeutics
| Datum | Zeit | Quelle | Überschrift |
|---|---|---|---|
| 01.4.2024 | 13:00 | Business Wire | Quince Therapeutics Provides Business Update and Reports.. |
| 22.2.2024 | 13:00 | Business Wire | Quince Therapeutics Launches Scientific Advisory Board |
| 15.2.2024 | 22:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 15.2.2024 | 13:00 | Business Wire | Quince Therapeutics Appoints Former Reata Pharmaceuticals.. |
| 07.2.2024 | 22:05 | Business Wire | Quince Therapeutics to Present at Oppenheimer 34th Annual.. |
| 02.2.2024 | 23:53 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 05.1.2024 | 22:01 | Edgar (US Regulatory) | Form 8-K/A - Current report: [Amend] |
| 04.1.2024 | 22:05 | Business Wire | Quince Therapeutics to Participate at Investor Events in.. |
| 03.1.2024 | 22:02 | Edgar (US Regulatory) | Form 8-K - Current report |
| 22.12.2023 | 22:08 | Edgar (US Regulatory) | Form 8-K - Current report |
| 15.12.2023 | 00:21 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 08.12.2023 | 22:06 | Edgar (US Regulatory) | Form 8-K - Current report |
Forum Quince Therapeutics
Keine Diskussionen Gefunden.Neuen Thread Erstellen
QNCX Historisch
| Zeitraum † | Handelsbeginn | Hoch | Niedrig | VWAP | Durchsch. Volumen | Änderung | % |
|---|---|---|---|---|---|---|---|
| 1 Woche | 1,03 | 1,12 | 0,93 | 1,05 | 77.033 | -0,118 | -11,46% |
| 1 Monat | 1,03 | 1,12 | 0,89 | 1,02 | 99.801 | -0,118 | -11,46% |
| 3 Monate | 1,26 | 1,42 | 0,89 | 1,13 | 71.469 | -0,348 | -27,62% |
| 6 Monate | 0,94 | 1,4301 | 0,84 | 1,11 | 81.616 | -0,028 | -2,98% |
| 1 Jahr | 1,57 | 1,74 | 0,84 | 1,23 | 138.054 | -0,658 | -41,91% |
| 3 Jahre | 39,98 | 121,98 | 0,5401 | 10,91 | 615.756 | -39,07 | -97,72% |
| 5 Jahre | 20,00 | 121,98 | 0,5401 | 15,27 | 433.001 | -19,09 | -95,44% |
